Autophagy-related long non-coding RNA MIR210HG plays a therapeutic role in hepatocellular carcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The long noncoding RNA MIR210HG is elevated in liver cancer, promoting tumor growth and inhibiting cell death. Targeting MIR210HG may offer a new strategy for hepatocellular carcinoma treatment.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Hepatocellular carcinoma (HCC) is a major global health concern with limited effective therapies.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development and progression.
- Autophagy is a cellular process implicated in cancer survival and treatment resistance.
Purpose Of The Study
- To investigate the role of the autophagy-related lncRNA MIR210HG in hepatocellular carcinoma (HCC).
- To evaluate MIR210HG as a potential therapeutic target for HCC.
Main Methods
- Analysis of MIR210HG expression and patient survival data from The Cancer Genome Atlas (TCGA).
- Quantitative reverse transcription PCR to measure MIR210HG levels in HCC and normal liver cells.
- In vitro and in vivo functional assays (CCK-8, Transwell, flow cytometry, western blot) to assess MIR210HG's impact on cell proliferation, invasion, apoptosis, and autophagy.
Main Results
- Elevated MIR210HG expression in HCC tissues correlated with poorer overall survival.
- MIR210HG was significantly upregulated in HCC cells compared to normal liver cells.
- Knockdown of MIR210HG suppressed HCC cell proliferation and autophagy while enhancing apoptosis.
Conclusions
- lncRNA MIR210HG promotes hepatocellular carcinoma progression by modulating autophagy.
- MIR210HG represents a promising therapeutic target for HCC treatment strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...